Unilesional mycosis fungoides treated with photodynamic therapy. A case report

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 17, Issue 2, 2008, Pages 75-78

  Hegyi, Juraj ^a   Frey, Tomáš ^a   Arenberger, Petr ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

MAL PDT; Methyl aminolevulinate; Mycosis fungoides

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; CORTICOSTEROID;

AGED; ARTICLE; BLEACHING; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MYCOSIS FUNGOIDES; PHOTODYNAMIC THERAPY; PSORIASIS VULGARIS; RADIATION DOSE; REMISSION;

AGED; AMINOLEVULINIC ACID; HUMANS; MALE; MYCOSIS FUNGOIDES; PHOTOCHEMOTHERAPY; SKIN NEOPLASMS;

EID: 47349112665     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Grebenova D, Cajthamlova H, Bartosova J et al. Selective destruction of leukaemic cells by photoactivation of 5-aminolaevulinic acid-induced protoporphyrin-IX. J Photochem Photobiol B. 1998;47:74-81.
2. Deahl JT, Oleinick NL, Evans HH. Large mutagenic lesions are induced by photodynamic therapy in murine LS5178Y lymphoblasts. Photochem Photobiol. 1993;58:259-64.
3. Leibovici L, Schoenfeld N, Yehoshua HA et al. Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer. Cancer. 1988;62:2297-300.
4. Dailey HA, Smith A. Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. Biochem J. 1984;223:441-5.
5. Moan J, Ma LW, Iani V. On the pharmacokinetics of topically applied 5-aminolevulinic acid and two of its esters. Int J Cancer. 2001;92:139-43.
6. Svanberg K, Andersson T, Killander D et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation. Br J Dermatol. 1994;130:743-51.
7. Orenstein A, Haik J, Tamir J et al. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application. Dermatol Surg. 2000;26:765-9.
8. Wolf P, Fink-Puches R, Cerroni L, Kerl H. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am Acad Dermatol. 1994;31:678-80.
9. Ammann R, Hunziker T. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am Acad Dermatol. 1995;33:541.
10. Leman JA, Dick DC, Morton CA. Topical 5-ALA photodynamic therapy for the treatment of cutaneous T-cell lymphoma. Clin Exp Dermatol. 2002;27:516-8.
11. Markham T, Sheahan K, Collins P. Topical 5-aminolaevulinic acid photodynamic therapy for tumour-stage mycosis fungoides. Br J Dermatol. 2001;144:1262-3.
12. Edstrom DW, Ros AM, Parvit A. Topical 5-aminolaevulinic acid based photodynamic therapy for mycosis fungoides - a study of cell proliferation and apoptosis before and after therapy. J Dermatol Sci. 1998;16:229.
13. Ebström DW, Porwit A, Ros AM. Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response. Acta Derm Venereol. 2001;81:184-8.
14. Paech V, Lorenzen T, Stoehr A, et al. Remission of a cutaneous mycosis fungoides after topical 5-ALA sensitisation and photodynamic therapy in a patient with advanced HIV-infection. Eur J Med Res. 2002;7:477-9.